BTEB1 Activators
The chemical class known as BTEB1 Activators comprises a diverse range of compounds that directly enhance the functional activity of BTEB1 or logically trigger signaling events leading to its activation. Phorbol 12-myristate 13-acetate, Forskolin, and 12-O-Tetradecanoylphorbol-13-acetate act as activators by influencing the PKC and cAMP pathways, showcasing their direct impact on BTEB1. Epidermal Growth Factor (EGF) and Anisomycin enhance BTEB1 activity by activating the ERK/MAPK and JNK pathways, respectively. Bradykinin and PMA serve as activators by enhancing the IL-33/ST2 signaling pathway, directly influencing BTEB1.
Lithium Chloride and Insulin directly activate BTEB1 by enhancing the PI3K/Akt pathway, emphasizing the specificity of their actions on BTEB1. This diverse array of compounds highlights the multifaceted nature of BTEB1 regulation and provides insights into the intricate network of signaling pathways governing its functional activity. The specificity of these activators in influencing defined pathways offers a foundation for understanding the molecular mechanisms underlying BTEB1 activation and suggests potential strategies for precise cellular control in the context of BTEB1-mediated processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate, a PKC activator, directly influences the PKC pathway. As BTEB1 is intricately linked to PKC-mediated processes, Phorbol 12-myristate 13-acetate serves as a crucial enhancer of BTEB1 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, enhances cAMP levels. Given that BTEB1 activity is modulated by cAMP, Forskolin serves as a potent enhancer of BTEB1. The elevation in cAMP levels potentiates BTEB1-mediated processes, directly influencing the functional activity of BTEB1 and highlighting the specific biochemical pathway through which Forskolin enhances BTEB1 activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin, a JNK activator, enhances the IL-33/ST2 signaling pathway. As BTEB1 is intricately connected to the IL-33/ST2 pathway, Anisomycin serves as a potent enhancer of BTEB1 activity. The activation of the IL-33/ST2 pathway by Anisomycin directly influences the functional activity of BTEB1, highlighting the specific biochemical pathway through which Anisomycin acts as an activator of BTEB1. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin, a peptide that activates the PLC/IP3 pathway, enhances the IL-33/ST2 signaling pathway. Given the connection between the IL-33/ST2 pathway and BTEB1, Bradykinin serves as a crucial enhancer of BTEB1 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride enhances the activity of the PI3K/Akt pathway. As BTEB1 is directly linked to the PI3K/Akt pathway, the increased activity of PI3K/Akt induced by Lithium Chloride directly influences the enhanced functional activity of BTEB1. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin enhances the activity of the PI3K/Akt pathway. Given the direct connection between BTEB1 and the PI3K/Akt pathway, the increased activity of PI3K/Akt induced by Insulin directly influences the enhanced functional activity of BTEB1. | ||||||